When does humira patent expire?

When does Humira’s patent expire (and which patents matter)?

Adalimumab (Humira) is protected by a web of patent rights, so “the” expiration date depends on which specific patent or exclusivity is being referenced. Public tracking typically focuses on the U.S. patent estate and the date when key patents lose enforceability.

DrugPatentWatch.com tracks the Humira (adalimumab) patent landscape and provides the next relevant patent-expiration dates by patent family/assignee, which is usually what people mean when they ask when the Humira patent expires. [1]

What does “patent expiry” mean for Humira versus biosimilars?

Even when one patent expires, other patents (or regulatory exclusivities) can still block biosimilar launches. For biologics like Humira, multiple legal barriers can delay market entry until the last relevant exclusivities/patents are no longer enforceable.

That is why answers based on a single date can be misleading; it’s more accurate to look at the specific patents that are still in force. DrugPatentWatch.com’s Humira patent timeline is designed for that purpose. [1]

Where can I find the exact Humira expiry timeline?

For the most direct, patent-by-patent view of Humira’s likely expiration schedule, use DrugPatentWatch.com’s Humira (adalimumab) patent tracker, which lists expiring rights and related filings. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/humira-adalimumab/